Magnetic Resonance Spectroscopy and Molecular Imaging of Metabolic Pathways in Cancer
癌症代谢途径的磁共振波谱和分子成像
基本信息
- 批准号:9755386
- 负责人:
- 金额:$ 11.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-12 至 2021-08-31
- 项目状态:已结题
- 来源:
- 关键词:BilateralCancer ModelCatalysisCell modelChelating AgentsClinicalClinical TrialsCollaborationsCommunitiesContrast MediaCoupledDetectionDevelopmentDoctor of PhilosophyEquipmentFaceGasesGlucoseHydrogenationImageImaging TechniquesInjectableInjectionsInternationalLabelLifeLipidsMRI ScansMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMalignant NeoplasmsMalignant neoplasm of prostateManuscriptsMetabolicMetabolic PathwayMetabolismMethodsModelingMolecularMolecular ProbesMonitorNMR SpectroscopyNuclearPeer ReviewPhysical ChemistryPlayPositron-Emission TomographyPreparationProcessProductionProtonsPublicationsPublishingPyruvateResearchResearch Peer ReviewResolutionResourcesRodent ModelRussiaScanningScientistScreening for cancerSeminalSideSignal TransductionSiteSurrogate MarkersSynthesis ChemistryTechniquesTimeTracerWorkaqueousarmbasecancer carecancer imagingcatalystchelationclinical translationcostfluorodeoxyglucosefluorodeoxyglucose positron emission tomographyglucose uptakehigh risk populationimaging detectionimaging probeimaging scientistin vivomagnetic fieldmagnetic resonance spectroscopic imagingmetal chelatormilligrammolecular imagingpre-clinicalradio frequencytooltreatment responsetumortumor metabolismuptakevolunteer
项目摘要
PROJECT SUMMARY
Parahydrogen Induced Polarization (PHIP) is an alternative hyperpolarization technique, which is based on
molecular addition of parahydrogen gas to an unsaturated molecular precursor. Unlike the more widespread
dissolution-Dynamic Nuclear Polarization (d-DNP), it is highly scalable and relatively inexpensive.
Nevertheless, it historically did NOT enjoy rapid preclinical adaptation and ultimate clinical translation as d-
DNP did for several critical reasons: (i) inability to hyperpolarize key metabolic contrast agents (e.g. pyruvate
or lactate), (ii) requirements for highly specialized hyperpolarizer hardware equipped with dual-channel radio
frequency NMR spectrometer, (iii) challenges for production of pure (from hydrogenation catalyst)
hyperpolarized solutions of hyperpolarized contrast agents. In 2014-2016, several seminal works have been
published in the field of PHIP demonstrating all of the above limitations can be overcome due to fundamental
advances in physical chemistry, synthetic chemistry and catalysis. Our international collaboration (established
in 2013) in particular has been leading most of these developments demonstrating that each of the above
challenges can be solved separately, and cheap metabolic contrast agents can be produced in principle
through new synthetic approaches, side-arm hydrogenation and magnetic field cycling, and heterogeneous
catalysis or catalyst chelation. In this proposal, we will explore the hypothesis that these separate
developments can be synergistically combined to accomplish the following Specific Aims: (i) Develop
molecular precursors for production of hyperpolarized C13-pyruvate via parahydrogen induced polarization
technique (PHIP); (ii) Optimize PHIP hyperpolarization using magnetic field cycling approach process to
maximize the percentage polarization and concentration of hyperpolarized C13-pyruvate; (iii) Develop efficient
method for producing hyperpolarized solutions using heterogeneous PHIP catalysis only or homogeneous
PHIP catalysis assisted by metal chelating agents to prepare pure aqueous solutions of hyperpolarized C13-
pyruvate; (iv) Validate the sensing capability (i.e. non-invasive sensing of elevated lactate metabolism in
cancer) of the developed hyperpolarized C13-pyruvate in cellular model of cancer. We assembled a highly
synergistic team of collaborating scientists from the US and Russia with proven three-year track record of
collaborative research and peer-reviewed publications documented by >20 peer-reviewed publications
(between US and Russian collaborators), and many more manuscripts under review and in preparation. The
US team will be comprised on imaging scientist, physical chemist, in vivo molecular imaging scientist and
others; and Russian team includes physical chemist/imaging scientist, catalytic chemist, cytologist, and others.
This team will focus on the above Aims by leveraging expertise, materials and equipment uniquely available in
Russian and US sub-teams to develop cheap and high-throughput production of hyperpolarized C13-pyruvate
– contrast agent that can revolutionize clinical cancer imaging.
项目摘要
仲氢诱导极化(PHIP)是一种替代性超极化技术,其基于
仲氢气体与不饱和分子前体的分子加成。与更广泛的
溶解动态核极化(d-DNP),它是高度可扩展的和相对便宜的。
然而,它在历史上并没有享受快速的临床前适应和最终的临床翻译作为d-
DNP的成功有几个关键原因:(i)不能使代谢造影剂(如丙酮酸盐)过氧化氢,
或乳酸盐),(ii)对配备有双通道无线电的高度专业化超极化器硬件的要求
频率NMR光谱仪,(iii)生产纯(来自氢化催化剂)的挑战
超极化造影剂的超极化溶液。在2014 - 2016年期间,
在PHIP领域中公开的证明了由于基本的
物理化学、合成化学和催化的进展。我们的国际合作(建立
在2013年),特别是一直在领导大多数这些发展表明,上述每一个
这些挑战可以单独解决,原则上可以生产廉价的代谢造影剂,
通过新的合成方法,侧臂氢化和磁场循环,
催化或催化剂螯合。在本提案中,我们将探讨这些分离的假设,
这些发展可以协同地结合起来,以实现以下具体目标:(一)发展
通过仲氢诱导极化产生超极化C13-丙酮酸盐的分子前体
技术(PHIP);(ii)使用磁场循环接近过程优化PHIP超极化,
最大化超极化C13-丙酮酸盐的极化百分比和浓度;(iii)开发有效的
仅使用非均相PHIP催化或均相PHIP催化制备超极化溶液的方法
金属螯合剂辅助PHIP催化制备超极化C13-
(iv)提高传感能力(即,在细胞中对升高的乳酸代谢的非侵入性传感),
癌症)的细胞模型中发展的超极化C13-丙酮酸盐。我们组织了一个高度
来自美国和俄罗斯的合作科学家组成的协同团队,
合作研究和同行评审出版物,由超过20篇同行评审出版物记录
(美国和俄罗斯合作者之间),以及更多的手稿正在审查和准备中。的
美国团队将由成像科学家、物理化学家、体内分子成像科学家和
俄罗斯团队包括物理化学家/成像科学家、催化化学家、细胞学家等。
该团队将通过利用专业知识、材料和设备来实现上述目标,
俄罗斯和美国子团队开发超极化C13-丙酮酸的廉价和高通量生产
- 可以彻底改变临床癌症成像的造影剂。
项目成果
期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pulse-Programmable Magnetic Field Sweeping of Parahydrogen-Induced Polarization by Side Arm Hydrogenation
- DOI:10.1021/acs.analchem.9b04501
- 发表时间:2020-01-07
- 期刊:
- 影响因子:7.4
- 作者:Joalland, Baptiste;Schmidt, Andreas B.;Chekmenev, Eduard Y.
- 通讯作者:Chekmenev, Eduard Y.
Toward Cleavable Metabolic/pH Sensing "Double Agents" Hyperpolarized by NMR Signal Amplification by Reversible Exchange.
- DOI:10.1002/chem.201802622
- 发表时间:2018-07-25
- 期刊:
- 影响因子:0
- 作者:Kidd BE;Mashni JA;Limbach MN;Shi F;Chekmenev EY;Hou Y;Goodson BM
- 通讯作者:Goodson BM
15 N MRI of SLIC-SABRE Hyperpolarized 15 N-Labelled Pyridine and Nicotinamide.
SLIC-SABRE 超极化 15 N 标记吡啶和烟酰胺的 15 N MRI。
- DOI:10.1002/chem.201900430
- 发表时间:2019
- 期刊:
- 影响因子:0
- 作者:Svyatova,Alexandra;Skovpin,IvanV;Chukanov,NikitaV;Kovtunov,KirillV;Chekmenev,EduardY;Pravdivtsev,AndreyN;Hövener,Jan-Bernd;Koptyug,IgorV
- 通讯作者:Koptyug,IgorV
Heterogeneous Parahydrogen Pairwise Addition to Cyclopropane.
- DOI:10.1002/cphc.201800690
- 发表时间:2018-10-19
- 期刊:
- 影响因子:0
- 作者:Salnikov OG;Kovtunov KV;Nikolaou P;Kovtunova LM;Bukhtiyarov VI;Koptyug IV;Chekmenev EY
- 通讯作者:Chekmenev EY
Chemical Exchange Reaction Effect on Polarization Transfer Efficiency in SLIC-SABRE.
化学交换反应对 SLIC-SABRE 偏振传输效率的影响。
- DOI:10.1021/acs.jpca.8b07163
- 发表时间:2018
- 期刊:
- 影响因子:0
- 作者:Pravdivtsev,AndreyN;Skovpin,IvanV;Svyatova,AlexandraI;Chukanov,NikitaV;Kovtunova,LarisaM;Bukhtiyarov,ValeriiI;Chekmenev,EduardY;Kovtunov,KirillV;Koptyug,IgorV;Hövener,Jan-Bernd
- 通讯作者:Hövener,Jan-Bernd
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eduard Chekmenev其他文献
Eduard Chekmenev的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eduard Chekmenev', 18)}}的其他基金
Rapid low-cost production of contrast agents for metabolic imaging
快速低成本生产代谢成像造影剂
- 批准号:
10572052 - 财政年份:2023
- 资助金额:
$ 11.82万 - 项目类别:
Hyperpolarized Diethyl Ether for Sub-second Pulmonary MRI
用于亚秒级肺部 MRI 的超极化乙醚
- 批准号:
10221779 - 财政年份:2020
- 资助金额:
$ 11.82万 - 项目类别:
Hyperpolarized Diethyl Ether for Sub-second Pulmonary MRI
用于亚秒级肺部 MRI 的超极化乙醚
- 批准号:
10040772 - 财政年份:2020
- 资助金额:
$ 11.82万 - 项目类别:
Magnetic Resonance Spectroscopy and Molecular Imaging of Metabolic Pathways in Cancer
癌症代谢途径的磁共振波谱和分子成像
- 批准号:
9381725 - 财政年份:2017
- 资助金额:
$ 11.82万 - 项目类别:
Pure parahydrogen-enhanced metabolic MRI contrast agents for molecular imaging
用于分子成像的纯仲氢增强代谢 MRI 造影剂
- 批准号:
9130178 - 财政年份:2015
- 资助金额:
$ 11.82万 - 项目类别:
Novel hyperpolarized C-13 and N-15 biomarkers for metabolic MR imaging of cancer
用于癌症代谢 MR 成像的新型超极化 C-13 和 N-15 生物标志物
- 批准号:
7941341 - 财政年份:2009
- 资助金额:
$ 11.82万 - 项目类别:
Novel hyperpolarized C-13 and N-15 biomarkers for metabolic MR imaging of cancer
用于癌症代谢 MR 成像的新型超极化 C-13 和 N-15 生物标志物
- 批准号:
7922512 - 财政年份:2008
- 资助金额:
$ 11.82万 - 项目类别:
Novel hyperpolarized C-13 and N-15 biomarkers for metabolic MR imaging of cancer
用于癌症代谢 MR 成像的新型超极化 C-13 和 N-15 生物标志物
- 批准号:
7914685 - 财政年份:2008
- 资助金额:
$ 11.82万 - 项目类别:
Novel hyperpolarized C-13 and N-15 biomarkers for metabolic MR imaging of cancer
用于癌症代谢 MR 成像的新型超极化 C-13 和 N-15 生物标志物
- 批准号:
7510655 - 财政年份:2008
- 资助金额:
$ 11.82万 - 项目类别:
Novel hyperpolarized C-13 and N-15 biomarkers for metabolic MR imaging of cancer
用于癌症代谢 MR 成像的新型超极化 C-13 和 N-15 生物标志物
- 批准号:
8088064 - 财政年份:2008
- 资助金额:
$ 11.82万 - 项目类别:
相似海外基金
Treatment research by the suppression of secretory phenomenon associated with cellular senescence in mouse prostate cancer model
通过抑制小鼠前列腺癌模型中与细胞衰老相关的分泌现象进行治疗研究
- 批准号:
21K09409 - 财政年份:2021
- 资助金额:
$ 11.82万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pancreatic cancer biomarker research by the exosome proteome analysis of the HGD rat pancreatic cancer model
HGD大鼠胰腺癌模型的外泌体蛋白质组分析研究胰腺癌生物标志物
- 批准号:
21K07910 - 财政年份:2021
- 资助金额:
$ 11.82万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identifying and manipulating molecular mechanisms controlling cancer stem cell metastatic potential in a human oral cancer model.
识别和操纵控制人类口腔癌模型中癌症干细胞转移潜力的分子机制。
- 批准号:
MR/V009494/1 - 财政年份:2021
- 资助金额:
$ 11.82万 - 项目类别:
Research Grant
Establishment of near-infrared photoimmunotherapy targeting CD73 using mouse lung cancer model
小鼠肺癌模型建立靶向CD73的近红外光免疫疗法
- 批准号:
21K07189 - 财政年份:2021
- 资助金额:
$ 11.82万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Synthetic Lethality Related to Over-Expression of Telomerase Reverse Transcriptase in a Prostate Cancer Model
前列腺癌模型中与端粒酶逆转录酶过度表达相关的合成致死率
- 批准号:
467101 - 财政年份:2021
- 资助金额:
$ 11.82万 - 项目类别:
Studentship Programs
Development of a Vascularized Brain Cancer Model with Built-in Immunity and Lymphatic System for Immune Cell/Drug Delivery and Clearance
开发具有内置免疫和淋巴系统的血管化脑癌模型,用于免疫细胞/药物输送和清除
- 批准号:
565148-2021 - 财政年份:2021
- 资助金额:
$ 11.82万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Characterizing the Behaviour of Myeloid-Derived Suppressor Cells in a 3D In Vitro cancer Model
表征 3D 体外癌症模型中骨髓源性抑制细胞的行为
- 批准号:
551138-2020 - 财政年份:2020
- 资助金额:
$ 11.82万 - 项目类别:
University Undergraduate Student Research Awards
Patient Derived Cancer Model (PDCM) Finder
患者衍生癌症模型 (PDCM) 查找器
- 批准号:
10260591 - 财政年份:2020
- 资助金额:
$ 11.82万 - 项目类别:
Establishment of visualizing oral cancer model and development of clinical ultrasonographic examination which detects initial cervical metastatic lymph node by oral cancer
可视化口腔癌模型的建立及口腔癌早期颈部转移淋巴结临床超声检查的进展
- 批准号:
20K10140 - 财政年份:2020
- 资助金额:
$ 11.82万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Advancing precision medicine through development of the canine comparative cancer model
通过开发犬类比较癌症模型推进精准医疗
- 批准号:
9910776 - 财政年份:2020
- 资助金额:
$ 11.82万 - 项目类别:














{{item.name}}会员




